NIH Announces $2M Funding for Psychedelic Research into Treating Substance-Use Disorders
Last week, the National Institutes of Health (NIH) announced funding for the development of psychedelic treatments for substance-use disorder. This latest announcement comes after three earlier notices posted by the NIH, which centered on funding opportunities for managing drug addiction using psychedelics. One of the postings would focus on understanding how psychedelics worked while the others would center on the use of these drugs on human subjects in clinical trials. In its recent statement, the federal agency revealed that it planned to allocate $2 million in grant money for research projects for the fiscal year 2025. This funding, which will…